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Abstract
Objective: To demonstrate that staged, consecutive, carotid endarterectomy (CEA) and coronary artery bypass grafting (CABG) are safe,
perhaps preferable, alternative for the treatment of patients with severe carotid and coronary artery disease. Methods: During an 8-year
period ending December 1999, 77 (2.1%) of 3633 consecutive patients who were referred for isolated coronary surgery were found to have
significant carotid disease and underwent CEA, and subsequently, CABG. The mean age was 65:2 ^ 5:9 years and 66 (85.7%) were males.
The majority (84.4%) had triple vessel and 19.4% had left main disease. Carotid disease was unilateral in 71 patients (92.2%) and bilateral in
six (7.8%), and 57 (74.0%) were neurologically asymptomatic. Only obstructions .70% were considered for endarterectomy. Results:
Eighty-three isolated CEAs were performed with direct clamping of the artery (mean 20:1 ^ 5:9 min) in all but one. There were no deaths.
There were two strokes (2.4%) and three (3.6%) myocardial infarctions (MI). The mean admission time was 6:0 ^ 3:5 days. The staging
interval was 32.4 days. During coronary surgery, a mean of 2.9 coronary grafts/patient was performed and all but one patient received at least
one IMA graft. One patient (1.3%) died. There were two cases (2.6%) of MI and three patients (3.9%) had a stroke. Hence, the overall rates of
perioperative mortality, MI and stroke were 1.3, 6.3 and 6.3%, respectively. The mean admission time was 8:3 ^ 6:0 days. Conclusions:
Staging of carotid and coronary operations resulted in low global perioperative mortality and morbidity rates in these high-risk patients and is
a good alternative therapeutic option. q 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Although a significant amount of information is currently
available with regard to the dilemma of myocardial revas-
cularisation in the presence of carotid arterial disease, the
choice of treatment for patients who present with severe
carotid artery stenosis that is incidentally found during
preparation for coronary artery bypass grafting (CABG) is
still a matter of debate. The options vary from a simulta-
neous (same anaesthetic) to a staged procedure, whereby
carotid endarterectomy (CEA) is performed several days
prior to (staged approach) or after (reversed staged
approach) coronary revascularisation. To date, no well-
designed prospective randomised trial has clarified this
problem. Each of these methods has its advantages and
disadvantages, which can be measured, essentially, by the
global mortality and incidence of MI and of stroke.
Since 1992, it has been our philosophy to manage these
patients by the staged approach. This decision resulted,
essentially, from the fact that in our country cardiac surgery
and vascular surgery are two different specialties, making it
more difficult to coordinate two surgical teams to perform
both procedures during the same anaesthetic session. The
purpose of this work was to evaluate our early results in 77
consecutive patients who underwent such surgery.
2. Materials and methods
During an 8-year period ending December 1999, 77
(2.1%) of 3633 consecutive patients who had isolated coron-
ary artery bypass grafting (CABG) underwent carotid, and
subsequently, coronary surgery for severe concomitant
arterial disease. To avoid the introduction of potentially
conflicting factors, patients who had associated procedures,
such as valvular surgery, and those who had undergone
unrelated carotid surgery in the past, were not included in
this series.
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2.1. Diagnosis and general management protocol
All patients were originally admitted to our hospital for
CABG and the diagnosis of internal carotid artery disease
was made during the preoperative clinical workup. They
underwent carotid artery evaluation on a selective basis,
mainly dependent on the auscultation of a bruit in the
neck and/or a history of neurological symptoms consistent
with cerebrovascular disease. Although most of these
patients had duplex studies, the diagnosis and severity of
the carotid disease was finally established in all cases by
carotid angiography.
Selection criteria for carotid surgery were constant
throughout and well defined, i.e. patients underwent CEA
if they had a haemodynamically significant lesion (luminal
diameter .70%, using the diameter of the distal internal
carotid artery as a reference) of either or both carotid
arteries, independent of the symptomatic neurological
status. During the period covered by this study, all patients
were treated using the staged approach, i.e. CEA was
performed first, followed by CABG at a second operation.
In patients with bilateral disease, surgery to each of the two
carotid arteries was performed in different anaesthetic
times.
In the majority of cases (66 patients; 85.7%) CEA was
performed in our Department of Vascular Surgery. Imme-
diately after surgery, they were admitted to the Coronary
Care Unit, where they usually stayed until the next morning
and then returned to the Vascular Department ward.
During the period mediating between hospital discharge
from CEA and re-admission for CABG, a cardiologist of our
own Department closely monitored these patients. As a rule,
the CABG was performed within a minimum time interval
of 2 weeks from the carotid surgery, during a different
period of hospitalisation, unless the cardiac condition
dictated earlier surgery (two cases). This interval was
dictated by the protocol in use in the Department of Vascu-
lar Surgery, which calls for a minimum period of 1 week of
anti-platelet aggregation followed by 1 week of suspension
prior to CABG.
2.2. Preoperative patients data
The clinical data of the 77 patients is detailed in Table 1.
The mean age was 65:2 ^ 5:9 years (range 49–81 years) and
66 (85.7%) were males. Nineteen (24.7%) patients were
diabetic, and 51 (66.2%) had dislipidemia. Thirty-four
(44.2%) and 43 (55.8%) patients were, respectively, in
class I/II and III/IV of the Canadian Cardiovascular Society.
A history of previous MI was recorded in 43 patients
(55.8%). Five (6.5%) patients, otherwise stable on the day
of carotid artery surgery, had been on intravenous anti-angi-
nal medication in the previous 2 days. Twenty-three patients
(29.9%) had peripheral vascular disease. Sixty-five patients
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Table 1
Preoperative clinical, angiographic and operative cardiac data of patients who had the staged procedure versus patients who had isolated CABG during the
same perioda
Variable Staged operation (%) Isolated CABG (%) P value
Patients (n) 77 3556
Mean age (years) 65.2 ^ 5.9 60.1 ^ 9.3 , 0.001
Female sex (14.2) (11.4) NS
Family history of CAD (22.1) (22.4) NS
Smoking (51.9) (55.5) NS
Diabetes mellitus (24.7) (21.5) NS
Dislipidemia (66.2) (54.5) NS
Hypertension (72.7) (56.8) 0.005
History of MI (55.8) (59.1) NS
Peripheral vascular disease (29.9) (9.5) , 0.0001
History of stroke or TIA (26.0) (4.5) , 0.0001
One vessel disease (2.6) (5.1) NS
Two vessels disease (13.0) (18.3) NS
Three vessels disease (84.4) (76.6) NS
Left main disease (19.4) (15.8) NS
Left ventricular function
Normal (49.3) (51.6) NS
Mild dysfunction (39.0) (32.5) NS
Moderate dysfunction (9.1) (11.1) NS
Severe dysfunction (2.6) (3.4) NS
Mean no. of coronary grafts 2.9 2.9 NS
Arterial conduit
Left IMA (98.7) (99.1) NS
Bilateral IMA (9.1) (25.2) , 0.0001
Coronary endarterectomy (19.5) (7.1) , 0.0001
a TIA, transient ischaemic attack; MI, myocardial infarction; CAD, coronary artery disease; NS, not significant.
(84.4%) had triple vessel coronary disease and 15 (19.4%)
had left main disease. Moderate or severe left ventricular
dysfunction (ejection fraction ,40%) was present in nine
cases (11.7%). There were no cases of redo-CABG among
these patients.
For comparison, data on 3556 patients without known
carotid disease subjected to isolated CABG during the
same period of time is also presented in Table 1. The staged
operation group was significantly older (65.2 years versus
60.1 years, P , 0:001), had more patients with cerebral
(26.0 versus 4.5%, P , 0:0001) and peripheral vascular
(29.9 versus 9.5%, P , 0:0001) disease, and with hyperten-
sion (72.2 versus 56.8%, P ¼ 0:005). This group also
presented a significantly higher incidence of patients who
had coronary endarterectomy and a lower incidence of use
of bilateral IMA.
The preoperative neurological symptoms and anatomy of
the carotid disease are shown in Table 2. Twenty patients
(26.0%) had neurological symptoms, including 11 patients
with permanent stroke and nine with transient symptoms
(five with transient ischaemic attacks and four with amauro-
sis fugax). Carotid disease was unilateral in 71 patients
(92.2 %) and bilateral in six (7.8%), with no cases of
contralateral occlusion.
2.3. Operative techniques — carotid and coronary surgery
In all but two cases (2.4%) the CEA was performed under
general anaesthesia. Invasive arterial blood pressure and
cardiac rhythm were continuously monitored. Direct clamp-
ing of the artery (mean 20 ^ 6 min) was used in all patients
but one who had a temporary shunt inserted.
The technique for coronary revascularisation involved
aortic and right atrial cannulation and mild systemic
hypothermic cardiopulmonary bypass (30–328C). A left
ventricular vent was routinely introduced through the right
superior pulmonary vein. We have adopted the method of
ventricular fibrillation for construction of the distal anasto-
mosis. Proximal anastomosis of vein grafts were
constructed during a single period of aortic side-clamping.
Internal mammary artery (AMI) grafts were used in all but
one patient (98.7%), including seven (9.1%) in whom both
AMIs were used. An average of 2.9 coronary artery
branches were bypassed per patient. Coronary endarterec-
tomies, mostly of the right, were performed in 15 patients
(19.4%). Cardiopulmonary bypass time was 64 ^ 18 min.
2.4. Data analysis
Perioperative events included those occurring within 30
days of surgery or during the same hospitalisation. Standard
statistical tests (Student t and x 2) were used for comparison
of data, and statistical significance was inferred for
P , 0:05.
3. Results
3.1. Carotid surgery and staging interval
There were 83 isolated CEAs performed in the 77 patients,
with no mortality. There were two cases (2.4%) of permanent
ipsilateral stroke. Cerebral computed tomography (CT)
showed an area of infarct in both cases and non-invasive
carotid artery evaluation revealed patency of the CEA site.
These two patients underwent CABG subsequently with a
staging interval of 55 and 40 days, respectively. Addition-
ally, two patients (2.4%) had transient ischaemic attacks
(TIA), with negative CT scans and permeable carotids.
There were no cases of contralateral central neurological
accidents. Four patients developed minor peripheral neuro-
logical deficits, of which two did not resolve during the post-
operative follow-up: one had a left vocal chordal palsy and
the other had isolated hypoglossal nerve palsy.
There were three (3.6%) cases of MI, all occurring in the
early (hospital) period and evolving with haemodynamic
stability. Four patients developed unstable angina and two
of them, who did not respond to intravenous medication,
required urgent CABG. One patient had an episode of
ventricular fibrillation during the carotid surgery, without
clinical consequences. Three patients were re-explored for
revision of haemostasis and one had a wound infection trea-
ted by debridement and antibiotics.
All patients returned home in a stable cardiac situation.
The time of hospital stay was 6:2 ^ 3:4 days. After hospital
discharge and through to the time of coronary surgery, there
was no mortality or new cases of neurological complications
or MI. Nevertheless, two patients (2.4%) developed
unstable angina and required hospitalisation with successful
medical control. The mean staging interval was 32.4 days.
3.2. Coronary surgery
There was one death (1.3 %) due to stroke. Seven patients
(9.1%) required inotropic support in the immediate post-
operative period. There were electrocardiogram (ECG)
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. 90% 9 11.7
Bilateral disease 6 7.8
a TIA, transient ischaemic attack.
criteria of perioperative MI in two patients (2.6%). Twenty-
three patients (29.9%) developed atrial arrhythmias (fibril-
lation and/or flutter) that required treatment and two patients
(2.6%) had an episode of ventricular fibrillation without
clinical consequences. Two patients (2.6%) were re-oper-
ated for bleeding and one for sternal dehiscence. Five
patients (6.5%) developed transient acute renal insufficiency
(creatinine $2.5 mg/dl), not requiring dialysis.
There were three cases (3.9%) of stroke, all ipsilateral to
the CEA. The one, which was the cause of the single in-
hospital death in this study, occurred in a patient with a
history of permanent stroke in the past and who was
submitted to bilateral CEA (the last performed 28 days
before CABG). This patient did not wake up from anaes-
thesia and died on postoperative day 10. The necropsy study
showed a major infarction of the right cerebral hemisphere
and extensive right carotid thrombosis. The second patient,
who also had a history of permanent stroke in the past, was
submitted to urgent CABG 6 days after left CEA, because of
untreatable unstable angina. In the immediate postoperative
period, he developed a severe and prolonged period of hypo-
tension as a result of major bleeding from the aortic cannu-
lation site, and a right hemiplegia was noted when he woke
up. The third patient sustained an ipsilateral stroke on post-
operative day 2, probably embolic from the CEA left site
(performed 27 days before), which was patent as assessed
by non-invasive means. Both patients were ambulatory,
albeit with sequelae, at discharge. There were no cases of
transient ischaemic attacks or reversible ischaemic neurolo-
gical deficit. The hospital stay was 8:3 ^ 6:0 days.
4. Discussion
The incidence of major neurological complications
occurring during the performance of coronary artery surgery
varies widely, depending on the definition and accuracy of
diagnosis, and has been reported between 1 and 6% [1].
Although the role of carotid disease in the genesis of
perioperative stroke in patients undergoing isolated myocar-
dial revascularisation remains incompletely defined,
because of the multifactorial aetiology, several reports indi-
cate that significant carotid artery stenosis is an important,
and for some the strongest, incremental risk factor [2–4].
Nevertheless, D’Agostino et al., estimated perioperative
risk at ,2% in patients with carotid stenosis ,50%, 10%
with stenosis 50–80%, and 11–19% with stenosis.80% [5].
Routine carotid evaluation before CABG has yielded
significant internal carotid stenosis (.70%) in 3–12% of
patients [1,6]. In our experience, the diagnosis of severe
carotid disease was secondarily made in 2.1% of the patients
who had been admitted for isolated CABG. However, this
could obviously be an underestimation of the real incidence
of carotid disease because routine preoperative evaluation
of all CABG patients, other than auscultation of bruits, was
not carried out. Many surgical groups perform carotid
duplex studies routinely in patients who are to undergo
CABG, but this has not proven to lead to a better outcome.
On the other hand, a controversy still exists in the literature
as to whether or not CEA is protective against stroke.
However, some randomised trials have now unequivocally
demonstrated a significant benefit of CEA over continued
medical treatment for patients with symptomatic, and more
recently, with asymptomatic severe carotid artery stenosis.
The North American Symptomatic Carotid Endarterectomy
Trial (NASCET) study [7] showed that in symptomatic
patients with 70–99% carotid stenosis, CEA decreased the
2-year rate of ipsilateral stroke from 26% (in medically trea-
ted patients) to 9%. The Asymptomatic Carotid Athero-
sclerosis Study (ACAS) study [8] demonstrated a reduction
in total ipsilateral neurological events in patients with.60%
carotid stenosis from 18 to 7%, over 5 years. These data may,
perhaps, be extrapolated to patients requiring CABG and
argue for an aggressive surgical approach in this population.
We believe that the rational approach for virtually all
patients who present with severe combined arterial disease
is to submit them to carotid surgery before myocardial
revascularisation. In this context, the surgical options are
then either a simultaneous procedure (same anaesthetic) or
a staged approach with CEA performed several days prior to
CABG. Proponents of both types of approaches have
published series proclaiming the safety of each technique.
However, no well-designed prospective randomised trial
has, until now, clarified this problem. Consequently, the
optimal strategy for management remains undefined and
each centre must select and analyse its own treatment policy
and compare the results with those described in other
published reports. In 1992, we adopted the staged approach
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Table 3
Studies reporting results with the staged approach
Series No. of patients MI Stroke Death Stroke1 death
Bernhard et al. [12] 16 3 (18.8%) 2 (12.5%) 5 (31.3%) 7 (43.5%)
Reul et al. [13] 164 ? 4 (2.4%) 8 (4.9%) 12 (7.3%)
Hertzer et al. [14] 24 1 (4.2%) 1 (4.2%) 1 (4.2%) 2 (8.4%)
Fagioly et al. [15] 17 ? 0 0 0
Carrel et al. [16] 45 4 (8.8%) 0 2 (2.2%) 2 (4.4%)
Coyle et al. [17] 45 ? 2 (4.4%) 1 (2.2%) 3 (6.6%)
Takach et al. [18] 257 12 (4.7%) 5 (1.9%) 4 (1.6%) 9 (3.5%)
Total 568 20 (5.8%) 14 (3.7%) 21 (3.7%) 35 (6.2%)
to treat all patients who present with concomitant arterial
carotid and coronary disease. Our decision was made
mainly because two different surgical teams (cardiac and
vascular) are involved, making a simultaneous procedure
difficult to coordinate. Most unstable patients can now be
stabilised medically in the coronary care unit. This was
successfully done in all (five) of our patients. If stabilisation
cannot be achieved or the coronary lesions are of extreme
severity, CABG should be performed first. As far as we can
recall, this was necessary in three of our cases.
Although the results with the simultaneous approach have
been well documented, fewer studies report results with the
staged approach (Table 3). The overall risk of mortality was
3.7%, that for MI was 5.8% and that for stroke was 2.5%,
with a composite rate of death and stroke of 6.2%. In
general, these studies also reported increased composite
rates of death and stroke in the simultaneous compared
with the staged group, although there was often a bias in
assigning higher risk patients to the simultaneous approach.
The same conclusion, suggesting that combined CABG and
CEA may be associated with a higher risk of stroke or death
than in staged procedures, was recently reported in a metaa-
nalysis by Borger et al. [11].
To the best of our knowledge, this is the first report of the
results of the staged operation used as the routine method to
treat all patients with identified concomitant carotid and
coronary arterial disease, and this may be one of its weak-
nesses, as we do not have a control group with which to
compare our results. In fact, all series dealing with the
results of the staged operation (Table 3) came from institu-
tions that also use other treatment options, including the
combined approach. In the beginning of this experience,
we were naturally concerned about the eventual conse-
quences of this method of treatment, with regards to the
eventual occurrence of MI during CEA and in the staging
interval. In the past, some influential studies had associated
CEA in patients with severe uncorrected coronary artery
disease with prohibitive rates of perioperative mortality
and of MI [9,10]. We agree that this group of patients
may be at higher risk of perioperative coronary ischaemic
events, but our results, reported herein, with no mortality
and an incidence of MI of 3.6%, appear to demonstrate the
relative safety of this approach.
Because patient selection is one critical factor in this
clinical evaluation, we intended to compare our series
(Table 4) only with others, which analyse the simultaneous
approach as a method to treat all patients. Even considering
that our series is relatively small by comparison with some
included, our global mortality (1.3%) and composite death
and stroke (6.3%) rates compare favourably with those
reported in the literature since 1992 for patients managed
using a simultaneous approach (Table 5). However, as it
probably might have been expected, our incidence of MI
was higher. On the other hand, we did not expect the rela-
tively high incidence of stroke after CABG (three patients;
3.9%), and also the fact that all were ipsilateral to the CEA
site. This result underscores the multifactorial aetiology of
stroke after CABG, particularly in these high-risk patients,
but is insufficient to question the value of prophylactic CEA
in reducing the incidence of stroke. We believe that the rate
of cerebrovascular accidents in our patients would have
been even higher if they had not undergone the CEA before
the CABG. However, the occurrence of three strokes, result-
ing from cerebral damage ipsilateral to the CEA, raises the
question of residual carotid disease. Perhaps routine duplex
scanning or angiography, which we have not used until now,
should be considered in these cases.
In conclusion, stroke after CABG is a dreadful complica-
tion. Carotid disease is significantly associated with this
neurological outcome. Hence, we believe that the rational
approach for the treatment of patients with severe combined
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Mortality 0 1 (1.3%) 1 (1.3%)c
MI 3 (3.6%) 2 (2.6%) 5 (6.3%)
Stroke 2 (2.4%) 3 (3.9%) 5 (6.3%)
Total stroke and mortality 5 (6.3%)
a SI indicates staging interval.
b Total number of carotid endarterectomies performed on the 77 patients.
c The patient who died is one of five who had stroke.
Table 5
Series reporting results of concomitant carotid and coronary operations since 1992
Series No. of patients MI Strokea Death Stroke1 death
Vermeulen et al. [19] 230 4 (1.8%) 7 (3.0%) 8 (3.5%) 15 (6.5%)
Akins et al. [21] 200 5 (2.5%) 6 (3.0%) 7 (3.5%) 13 (6.5%)
Daily et al. [23] 100 1 (1.0%) 0 4 (4.0%) 4 (4.0%)
Trachiotis et al. [24] 88 0 4 (4.5%) 3 (3.4%) 7 (7.9%)
Darling et al. [20] 420 ? 5 (1%) 10 (2.4%) 15 (3.4%)
Plestis et al. [25] 213 5 (2.3%) 11 (5.1%) 12 (5.6%) 23 (10.7%)
Evagelopoulos et al. [22] 313 10 (2.2%) 7 (2.2%) 28 (8.9%) 35 (11.1%)
Khaitan et al. [26] 121 ? 7 (5.8%) 7 (5.8%) 14 (11.6%)
Total 1685 25 (2.2%) 47 (2.8%) 79 (4.7%) 126 (7.5%)
a Reversible or permanent stroke.
arterial disease is to submit them to carotid surgery before
myocardial revascularisation. The results reported in this
study showed that good results are possible with the staged
approach even in high-risk patients.
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